How to Improve Anti-Müllerian Hormone Naturally

How to Improve Anti-Müllerian Hormone Naturally

Yes — AMH can respond to lifestyle and nutritional intervention, though the degree of change depends heavily on why it's low in the first place. Vitamin D repletion, antioxidant support, and reducing chronic inflammation show the most consistent evidence. The exception: age-related ovarian decline is largely irreversible, so timing and realistic expectations matter.

---

What Is AMH and Why Does It Matter?

Anti-Müllerian hormone is produced by the granulosa cells of small antral and pre-antral follicles in the ovaries. Clinically, it is the most reliable marker of ovarian reserve — how many eggs you have remaining and how responsive your ovaries are likely to be during fertility treatment. It doesn't fluctuate across the menstrual cycle the way estradiol or FSH do, which makes it a stable, repeatable test (Broer et al., Human Reproduction Update 2014; PMID: 24431682).

In men, AMH is produced by Sertoli cells in the testes and reflects testicular function, though the fertility conversation around AMH is almost entirely centered on ovarian reserve in women.

Normal AMH ranges vary by age, but a value below 1.0 ng/mL is generally considered low ovarian reserve. Values above 3.5 ng/mL can indicate polycystic ovary syndrome (PCOS), where excess follicles produce disproportionately high AMH. For a deeper look at how AMH behaves in PCOS specifically, see what happens to anti-Müllerian hormone with PCOS.

AMH is not a disease diagnosis — it is a signal. And like many biomarkers, its trajectory is influenced by factors you can control.

---

The Modifiable Drivers of Low AMH

Before reaching for supplements, it's worth understanding the mechanisms most likely responsible for suboptimal AMH. The three best-supported modifiable drivers are:

1. Vitamin D deficiency. Ovarian granulosa cells express vitamin D receptors, and several cross-sectional studies report significant positive correlations between serum 25(OH)D and AMH levels. A 2015 study in the European Journal of Clinical Nutrition found that women with vitamin D deficiency had significantly lower AMH than vitamin D-sufficient controls (Irani & Merhi, European Journal of Clinical Nutrition 2014; PMID: 24424076).

2. Oxidative stress. High reactive oxygen species (ROS) accelerate follicular apoptosis — essentially destroying eggs before they mature. Antioxidants such as CoQ10 and melatonin have been studied for their ability to reduce oocyte oxidative damage and support mitochondrial function in granulosa cells (Ben-Meir et al., Aging Cell 2015; PMID: 25754372).

3. Chronic low-grade inflammation. Elevated inflammatory cytokines (IL-6, TNF-α) are associated with reduced ovarian follicle recruitment. Women with elevated CRP tend to have lower AMH, independent of age and BMI.

Additionally, environmental toxin exposure — particularly endocrine-disrupting chemicals (EDCs) like BPA and phthalates — has been linked to accelerated follicular depletion. Reducing EDC exposure through diet and household product choices is a low-cost, evidence-adjacent intervention.

---

Nutrients and Supplements With Evidence for AMH Support

Vitamin D3 + K2

Vitamin D is the most studied nutrient in the AMH conversation. Supplementation trials in women undergoing IVF showed that achieving 25(OH)D levels above 30 ng/mL was associated with better ovarian response and higher AMH. The K2 (MK-7) form is typically paired with D3 to support proper calcium metabolism and prevent arterial calcification at higher D3 doses.

Target serum 25(OH)D: 40–60 ng/mL. This usually requires 2,000–5,000 IU of D3 daily depending on baseline, body weight, and sun exposure — always guide dosing from a blood test.

CoQ10 (Ubiquinol)

CoQ10 is a mitochondrial cofactor that declines with age. Since egg maturation is one of the most energy-intensive biological processes, CoQ10 has been hypothesized — and studied — as a way to support oocyte quality. A randomized controlled trial found that CoQ10 supplementation (600 mg/day) before IVF improved ovarian response in poor responders, increasing the number of mature oocytes retrieved (Xu et al., Journal of Ovarian Research 2018; PMID: 30208979).

While that trial measured oocyte yield rather than AMH directly, improving mitochondrial function in granulosa cells is mechanistically plausible as a support for ongoing follicular health.

DHEA

DHEA (dehydroepiandrosterone) is an adrenal androgen precursor that supports intraovarian androgen production. Several small RCTs in women with diminished ovarian reserve found that 75 mg/day of DHEA for 4–6 months improved AMH, antral follicle count, and IVF outcomes (Gleicher et al., Reproductive BioMedicine Online 2010; PMID: 20093100). DHEA is a borderline-aggressive intervention and should only be used under the guidance of a reproductive endocrinologist, especially since elevated androgens can worsen PCOS-related symptoms.

Myo-Inositol

Myo-inositol is well-studied in PCOS, where it improves insulin sensitivity and reduces hyperinsulinemia — a driver of excessive androgen production and disrupted folliculogenesis. In PCOS, elevated AMH is part of the problem, not a goal. For women with normal or low AMH alongside insulin resistance, myo-inositol (2–4 g/day) may help normalize the hormonal environment that influences follicle recruitment. To understand the AMH picture in PCOS more completely, the article on normal AMH levels in PCOS breaks down what the ranges actually mean.

Omega-3 Fatty Acids (EPA/DHA)

Omega-3s reduce prostaglandin-driven inflammation and appear to support ovarian function through anti-inflammatory mechanisms. Observational data from the EARTH study at Harvard found that higher dietary omega-3 intake was associated with better ovarian reserve markers in women undergoing fertility evaluation. EPA and DHA at 1,000–2,000 mg combined daily are a widely recommended baseline for reproductive health.

---

Dietary Patterns That Support Ovarian Reserve

No single food dramatically moves AMH, but consistent dietary patterns shape the hormonal and inflammatory environment that follicle development depends on.

Mediterranean-style eating — rich in olive oil, fatty fish, legumes, leafy vegetables, and low in ultra-processed foods — is associated with better IVF outcomes and lower markers of ovarian aging in observational studies. The antioxidant density of this pattern likely plays a central role.

Key dietary priorities:

• Zinc-rich foods: oysters, pumpkin seeds, grass-fed beef — zinc is essential for follicle-stimulating hormone (FSH) receptor signaling
• Folate-rich foods: dark leafy greens, lentils, asparagus — support DNA methylation in developing oocytes. If you're building folate intake through diet, the guide on how to improve folate levels naturally covers food sources and bioavailability in detail
• Vitamin A from food: egg yolks and liver provide preformed retinol that supports steroidogenesis in granulosa cells
• Limit alcohol: even moderate alcohol consumption has been associated with lower AMH in some cross-sectional analyses
• Limit soy isoflavones in high doses: at food-level intake, soy is likely neutral; at supplement doses (100+ mg/day isoflavones), phytoestrogen activity may interfere with FSH signaling

---

Lifestyle Factors: Sleep, Stress, and Body Weight

Sleep quality deserves particular attention. Melatonin — produced in darkness — concentrates in follicular fluid at levels significantly higher than in blood, suggesting a direct protective role against follicular oxidative stress. Consistently poor sleep reduces melatonin production and raises cortisol, both of which are unfavorable for follicle health. For anyone dealing with nighttime waking that disrupts sleep quality, the article on supplements for sleep maintenance insomnia covers the evidence-based options.

Chronic psychological stress elevates cortisol, which suppresses GnRH pulsatility and downstream LH/FSH — the signals that drive follicle recruitment. Adaptogenic herbs like Ashwagandha (KSM-66, 600 mg/day) have well-documented cortisol-lowering effects in clinical trials and may help restore the neuroendocrine environment that healthy follicular development requires.

Body weight affects AMH in a non-linear way. Obesity is associated with lower AMH through inflammatory and insulin-mediated mechanisms. Being significantly underweight (low body fat, hypothalamic amenorrhea) suppresses gonadotropins and may also suppress AMH. The functional sweet spot for ovarian reserve markers appears to be a healthy BMI with adequate — not excessive — body fat.

Vigorous over-exercise (training volume typical of competitive endurance athletes) can suppress hypothalamic function and is associated with lower AMH. This is distinct from regular moderate exercise, which appears beneficial or neutral.

---

What to Expect: Timelines and Realistic Outcomes

AMH reflects the pool of small developing follicles, which take approximately 3–6 months to progress through the early stages of recruitment. This means any intervention — nutritional or otherwise — needs at least 3 months of consistent application before you retest and draw conclusions. Most intervention studies use 3–6 month windows.

Realistic expectations:

• Vitamin D repletion: modest but consistent AMH improvement in deficient women, typically within 3–4 months
• CoQ10: primarily oocyte quality support; AMH effects are indirect and slower
• DHEA: most studied in diminished ovarian reserve; meaningful changes reported at 4–6 months in the Gleicher data
• Lifestyle optimization (sleep, stress, diet): foundational — enables the above interventions to work better

If you are postpartum and monitoring AMH recovery, normal values take time to stabilize. The article on normal AMH levels postpartum provides context on what to expect during that specific window.

---

What This Means for Your Formula

Ones builds personalized supplement formulas from blood work, wearable data, and health history — which means if your AMH, vitamin D, and inflammatory markers are part of your panel, the formula reflects those specific findings rather than a generic fertility stack.

For AMH support, the most clinically relevant ingredients in the Ones catalog include:

• Vitamin D3 + K2 (MK-7): Ones includes D3 paired with MK-7 at doses calibrated to your actual 25(OH)D level — not a flat 1,000 IU that may do nothing for a severely deficient individual
• CoQ10/Ubiquinol (200 mg): Ones includes ubiquinol, the active reduced form with superior absorption, at 200 mg — a dose within the range studied for mitochondrial support in reproductive health research
• Omega-3 (EPA/DHA): included where omega-3 index or dietary pattern data suggests insufficiency, targeting the 1,000–2,000 mg combined EPA/DHA range associated with reduced ovarian inflammatory burden

Because Ones analyzes your data rather than guessing, the AI practitioner can distinguish between someone who is vitamin D replete (and won't benefit from more D3) versus someone at 18 ng/mL who needs a meaningful therapeutic dose. That distinction is exactly what makes personalized formulas more useful than off-the-shelf fertility supplements.

---

Key Takeaways

• AMH is a stable marker of ovarian reserve, but it is not completely fixed — nutritional and lifestyle factors can influence it, particularly when a deficiency or modifiable driver is present
• Vitamin D repletion is the most evidence-supported nutritional intervention for low AMH in deficient women; target serum 25(OH)D of 40–60 ng/mL
• CoQ10 (ubiquinol) supports mitochondrial function in granulosa cells and has been shown to improve ovarian response in IVF poor responders at 600 mg/day
• Chronic sleep disruption, elevated cortisol, and poor diet create an inflammatory and hormonal environment that accelerates follicular depletion — addressing these is foundational
• DHEA may meaningfully improve AMH in women with diminished ovarian reserve, but requires medical supervision due to androgenic risk
• Allow at least 3–6 months of consistent intervention before retesting AMH; follicle development timelines mean results won't appear overnight

---

Always consult a reproductive endocrinologist or licensed healthcare provider before making decisions about fertility treatment or adding new supplements to your routine.